HEADER VIRAL PROTEIN 03-MAY-20 6WTT TITLE CRYSTALS STRUCTURE OF THE SARS-COV-2 (COVID-19) MAIN PROTEASE WITH TITLE 2 INHIBITOR GC-376 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A, B, C; COMPND 4 EC: 3.4.22.69; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: GC-376 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: REP, 1A-1B; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COVID COVID19 COVID-19 SARS SARS COV2 COV NCOV 19 CORONAVIRUS MAIN KEYWDS 2 PROTEASE 3CL MPRO PRO, VIRAL PROTEIN, GC376, GC-376, PEPTIDOMIMETIC, KEYWDS 3 PROTEASE, CYSTEINE EXPDTA X-RAY DIFFRACTION AUTHOR M.SACCO,C.MA,Y.CHEN,J.WANG REVDAT 7 18-OCT-23 6WTT 1 JRNL REVDAT 6 08-SEP-21 6WTT 1 JRNL REVDAT 5 25-NOV-20 6WTT 1 COMPND REMARK HET HETNAM REVDAT 5 2 1 HETSYN FORMUL LINK ATOM REVDAT 4 12-AUG-20 6WTT 1 JRNL REVDAT 3 01-JUL-20 6WTT 1 JRNL REVDAT 2 24-JUN-20 6WTT 1 JRNL HETSYN REVDAT 1 20-MAY-20 6WTT 0 JRNL AUTH C.MA,M.D.SACCO,B.HURST,J.A.TOWNSEND,Y.HU,T.SZETO,X.ZHANG, JRNL AUTH 2 B.TARBET,M.T.MARTY,Y.CHEN,J.WANG JRNL TITL BOCEPREVIR, GC-376, AND CALPAIN INHIBITORS II, XII INHIBIT JRNL TITL 2 SARS-COV-2 VIRAL REPLICATION BY TARGETING THE VIRAL MAIN JRNL TITL 3 PROTEASE. JRNL REF CELL RES. V. 30 678 2020 JRNL REFN ISSN 1001-0602 JRNL PMID 32541865 JRNL DOI 10.1038/S41422-020-0356-Z REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.MA,M.D.SACCO,B.HURST,J.A.TOWNSEND,Y.HU,T.SZETO,X.ZHANG, REMARK 1 AUTH 2 B.TARBET,M.T.MARTY,Y.CHEN,J.WANG REMARK 1 TITL BOCEPREVIR, GC-376, AND CALPAIN INHIBITORS II, XII INHIBIT REMARK 1 TITL 2 SARS-COV-2 VIRAL REPLICATION BY TARGETING THE VIRAL MAIN REMARK 1 TITL 3 PROTEASE. REMARK 1 REF BIORXIV 2020 REMARK 1 REFN ISSN 2692-8205 REMARK 1 PMID 32511378 REMARK 1 DOI 10.1101/2020.04.20.051581 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.MA,M.D.SACCO,B.HURST,J.A.TOWNSEND,Y.HU,T.SZETO,X.ZHANG, REMARK 1 AUTH 2 B.TARBET,M.T.MARTY,Y.CHEN,J.WANG REMARK 1 TITL BOCEPREVIR, GC-376, AND CALPAIN INHIBITORS II, XII INHIBIT REMARK 1 TITL 2 SARS-COV-2 VIRAL REPLICATION BY TARGETING THE VIRAL MAIN REMARK 1 TITL 3 PROTEASE. REMARK 1 REF CELL RES. 2020 REMARK 1 REFN ISSN 1001-0602 REMARK 1 PMID 32541865 REMARK 1 DOI 10.1038/S41422-020-0356-Z REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.56 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 50104 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.300 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 2733 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3709 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.72 REMARK 3 BIN R VALUE (WORKING SET) : 0.3890 REMARK 3 BIN FREE R VALUE SET COUNT : 171 REMARK 3 BIN FREE R VALUE : 0.3960 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6983 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 107 REMARK 3 SOLVENT ATOMS : 327 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.55000 REMARK 3 B22 (A**2) : 2.55000 REMARK 3 B33 (A**2) : -8.27000 REMARK 3 B12 (A**2) : 1.27000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.284 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.253 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.285 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.285 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7254 ; 0.009 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 6541 ; 0.006 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9844 ; 1.588 ; 1.649 REMARK 3 BOND ANGLES OTHERS (DEGREES): 15189 ; 1.287 ; 1.584 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 903 ; 8.053 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 356 ;33.282 ;23.202 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1149 ;15.945 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 33 ;18.818 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 940 ; 0.069 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8149 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1514 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6WTT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-MAY-20. REMARK 100 THE DEPOSITION ID IS D_1000248996. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-APR-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52883 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 9.500 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : 0.88900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 5RGG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15 % PEG 2K, 10 % 1,6-HEXD, 0.2 M REMARK 280 NACL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 106.67467 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 53.33733 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 53.33733 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 106.67467 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -83.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -53.33733 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 577 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 628 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 631 LIES ON A SPECIAL POSITION. REMARK 375 HOH C 570 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 303 REMARK 465 THR A 304 REMARK 465 HIS A 305 REMARK 465 HIS A 306 REMARK 465 HIS A 307 REMARK 465 HIS A 308 REMARK 465 HIS A 309 REMARK 465 HIS A 310 REMARK 465 VAL B 303 REMARK 465 THR B 304 REMARK 465 HIS B 305 REMARK 465 HIS B 306 REMARK 465 HIS B 307 REMARK 465 HIS B 308 REMARK 465 HIS B 309 REMARK 465 HIS B 310 REMARK 465 VAL C 303 REMARK 465 THR C 304 REMARK 465 HIS C 305 REMARK 465 HIS C 306 REMARK 465 HIS C 307 REMARK 465 HIS C 308 REMARK 465 HIS C 309 REMARK 465 HIS C 310 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 TYR C 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 VAL C 233 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 27 -177.02 -170.66 REMARK 500 ASP A 33 -132.89 42.27 REMARK 500 ASP A 48 53.05 -93.28 REMARK 500 ASN A 72 59.07 -114.56 REMARK 500 ASN A 84 -121.95 49.24 REMARK 500 ASN A 119 45.83 34.74 REMARK 500 ASN A 142 128.82 -39.79 REMARK 500 TYR A 154 -114.50 54.81 REMARK 500 SER A 301 24.83 -149.72 REMARK 500 ASP B 33 -119.01 43.19 REMARK 500 ASN B 51 63.67 -156.83 REMARK 500 ASN B 84 -114.89 56.36 REMARK 500 PRO B 122 108.17 -57.38 REMARK 500 ASP B 155 17.46 51.85 REMARK 500 CYS B 160 -17.40 -141.37 REMARK 500 ARG B 217 20.70 -140.98 REMARK 500 ASP C 33 -123.50 41.51 REMARK 500 ASP C 48 59.43 -101.65 REMARK 500 ASN C 51 77.46 -154.39 REMARK 500 ASN C 84 -117.80 52.39 REMARK 500 SER C 147 151.16 -49.92 REMARK 500 TYR C 154 -126.27 57.01 REMARK 500 PRO C 184 49.24 -83.70 REMARK 500 ALA C 191 96.82 -69.50 REMARK 500 ASN C 214 52.98 -112.98 REMARK 500 ARG C 217 1.55 -151.53 REMARK 500 LEU C 282 18.10 59.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 625 DISTANCE = 6.21 ANGSTROMS REMARK 525 HOH A 626 DISTANCE = 6.26 ANGSTROMS REMARK 525 HOH A 627 DISTANCE = 7.06 ANGSTROMS REMARK 525 HOH A 628 DISTANCE = 7.11 ANGSTROMS REMARK 525 HOH A 629 DISTANCE = 7.42 ANGSTROMS REMARK 525 HOH A 630 DISTANCE = 7.53 ANGSTROMS REMARK 525 HOH A 631 DISTANCE = 10.31 ANGSTROMS REMARK 525 HOH B 619 DISTANCE = 5.96 ANGSTROMS REMARK 525 HOH B 620 DISTANCE = 6.20 ANGSTROMS REMARK 525 HOH B 621 DISTANCE = 7.34 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 403 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN B 221 O REMARK 620 2 ASN B 221 OD1 68.3 REMARK 620 3 PHE B 223 O 109.8 84.5 REMARK 620 4 ASP B 263 O 143.9 126.7 104.6 REMARK 620 5 ASP B 263 OD1 85.5 153.1 111.1 72.1 REMARK 620 6 HOH B 524 O 71.7 92.6 175.9 74.8 72.8 REMARK 620 N 1 2 3 4 5 REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: (1S,2S)-2-({N-[(BENZYLOXY)CARBONYL]-L-LEUCYL}AMINO)- REMARK 630 1-HYDROXY-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPANE-1-SULFONIC ACID REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 K36 A 401 REMARK 630 K36 B 401 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: PHQ LEU 04F REMARK 630 DETAILS: NULL REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: (1R,2S)-2-({N-[(BENZYLOXY)CARBONYL]-L-LEUCYL}AMINO)- REMARK 630 1-HYDROXY-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPANE-1-SULFONIC ACID REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 B1S C 401 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: PHQ LEU B1Y REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue K36 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide K36 B 401 and CYS B REMARK 800 145 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide UCS C 401 and CYS C REMARK 800 145 DBREF 6WTT A 1 304 UNP P0DTD1 R1AB_SARS2 3264 3567 DBREF 6WTT B 1 304 UNP P0DTD1 R1AB_SARS2 3264 3567 DBREF 6WTT C 1 304 UNP P0DTD1 R1AB_SARS2 3264 3567 SEQADV 6WTT HIS A 305 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS A 306 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS A 307 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS A 308 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS A 309 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS A 310 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS B 305 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS B 306 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS B 307 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS B 308 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS B 309 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS B 310 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS C 305 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS C 306 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS C 307 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS C 308 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS C 309 UNP P0DTD1 EXPRESSION TAG SEQADV 6WTT HIS C 310 UNP P0DTD1 EXPRESSION TAG SEQRES 1 A 310 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 A 310 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 A 310 LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO SEQRES 4 A 310 ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO SEQRES 5 A 310 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN SEQRES 6 A 310 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 A 310 GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL SEQRES 8 A 310 ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 A 310 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 A 310 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 A 310 ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 A 310 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 A 310 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 A 310 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR SEQRES 15 A 310 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 A 310 THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU SEQRES 17 A 310 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 A 310 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 A 310 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 A 310 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 A 310 VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN SEQRES 22 A 310 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU SEQRES 23 A 310 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 A 310 CYS SER GLY VAL THR HIS HIS HIS HIS HIS HIS SEQRES 1 B 310 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 B 310 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 B 310 LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO SEQRES 4 B 310 ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO SEQRES 5 B 310 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN SEQRES 6 B 310 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 B 310 GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL SEQRES 8 B 310 ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 B 310 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 B 310 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 B 310 ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 B 310 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 B 310 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 B 310 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR SEQRES 15 B 310 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 B 310 THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU SEQRES 17 B 310 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 B 310 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 B 310 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 B 310 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 B 310 VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN SEQRES 22 B 310 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU SEQRES 23 B 310 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 B 310 CYS SER GLY VAL THR HIS HIS HIS HIS HIS HIS SEQRES 1 C 310 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 C 310 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 C 310 LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO SEQRES 4 C 310 ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO SEQRES 5 C 310 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN SEQRES 6 C 310 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 C 310 GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL SEQRES 8 C 310 ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 C 310 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 C 310 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 C 310 ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 C 310 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 C 310 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 C 310 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR SEQRES 15 C 310 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 C 310 THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU SEQRES 17 C 310 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 C 310 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 C 310 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 C 310 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 C 310 VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN SEQRES 22 C 310 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU SEQRES 23 C 310 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 C 310 CYS SER GLY VAL THR HIS HIS HIS HIS HIS HIS HET K36 A 401 29 HET PEG A 402 7 HET GOL A 403 6 HET CL A 404 1 HET CL A 405 1 HET CL A 406 1 HET MG A 407 1 HET K36 B 401 29 HET CL B 402 1 HET MG B 403 1 HET B1S C 401 29 HET CL C 402 1 HETNAM K36 (1S,2S)-2-({N-[(BENZYLOXY)CARBONYL]-L-LEUCYL}AMINO)-1- HETNAM 2 K36 HYDROXY-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPANE-1- HETNAM 3 K36 SULFONIC ACID HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM GOL GLYCEROL HETNAM CL CHLORIDE ION HETNAM MG MAGNESIUM ION HETNAM B1S (1R,2S)-2-({N-[(BENZYLOXY)CARBONYL]-L-LEUCYL}AMINO)-1- HETNAM 2 B1S HYDROXY-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPANE-1- HETNAM 3 B1S SULFONIC ACID HETSYN K36 GC376 HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 K36 2(C21 H31 N3 O8 S) FORMUL 5 PEG C4 H10 O3 FORMUL 6 GOL C3 H8 O3 FORMUL 7 CL 5(CL 1-) FORMUL 10 MG 2(MG 2+) FORMUL 14 B1S C21 H31 N3 O8 S FORMUL 16 HOH *327(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 ASN A 53 ARG A 60 1 8 HELIX 4 AA4 SER A 62 HIS A 64 5 3 HELIX 5 AA5 ILE A 200 ASN A 214 1 15 HELIX 6 AA6 THR A 226 TYR A 237 1 12 HELIX 7 AA7 THR A 243 LEU A 250 1 8 HELIX 8 AA8 LEU A 250 GLY A 258 1 9 HELIX 9 AA9 ALA A 260 GLY A 275 1 16 HELIX 10 AB1 THR A 292 CYS A 300 1 9 HELIX 11 AB2 SER B 10 GLY B 15 1 6 HELIX 12 AB3 HIS B 41 CYS B 44 5 4 HELIX 13 AB4 THR B 45 MET B 49 5 5 HELIX 14 AB5 ASN B 53 LYS B 61 1 9 HELIX 15 AB6 SER B 62 HIS B 64 5 3 HELIX 16 AB7 ILE B 200 ASN B 214 1 15 HELIX 17 AB8 THR B 226 TYR B 237 1 12 HELIX 18 AB9 THR B 243 LEU B 250 1 8 HELIX 19 AC1 LEU B 250 GLY B 258 1 9 HELIX 20 AC2 ALA B 260 GLY B 275 1 16 HELIX 21 AC3 THR B 292 SER B 301 1 10 HELIX 22 AC4 SER C 10 GLY C 15 1 6 HELIX 23 AC5 HIS C 41 CYS C 44 5 4 HELIX 24 AC6 SER C 46 LEU C 50 5 5 HELIX 25 AC7 ASN C 53 ARG C 60 1 8 HELIX 26 AC8 LYS C 61 PHE C 66 5 6 HELIX 27 AC9 ILE C 200 ASN C 214 1 15 HELIX 28 AD1 THR C 226 TYR C 237 1 12 HELIX 29 AD2 THR C 243 LEU C 250 1 8 HELIX 30 AD3 LEU C 250 GLY C 258 1 9 HELIX 31 AD4 ALA C 260 GLY C 275 1 16 HELIX 32 AD5 THR C 292 CYS C 300 1 9 SHEET 1 AA1 7 GLN A 74 LEU A 75 0 SHEET 2 AA1 7 PHE A 66 GLN A 69 -1 N VAL A 68 O LEU A 75 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 89 N VAL A 36 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N GLN A 83 O VAL A 86 SHEET 1 AA2 5 TYR A 101 PHE A 103 0 SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O TYR A 126 N VAL A 114 SHEET 1 AA3 3 TYR A 101 PHE A 103 0 SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 AA4 7 VAL B 73 LEU B 75 0 SHEET 2 AA4 7 PHE B 66 ALA B 70 -1 N ALA B 70 O VAL B 73 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O GLY B 29 N VAL B 18 SHEET 5 AA4 7 VAL B 35 PRO B 39 -1 O VAL B 35 N LEU B 32 SHEET 6 AA4 7 VAL B 86 VAL B 91 -1 O LEU B 87 N CYS B 38 SHEET 7 AA4 7 VAL B 77 GLN B 83 -1 N GLN B 83 O VAL B 86 SHEET 1 AA5 5 TYR B 101 PHE B 103 0 SHEET 2 AA5 5 CYS B 156 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 AA5 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA5 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA5 5 SER B 121 ALA B 129 -1 O CYS B 128 N PHE B 112 SHEET 1 AA6 3 TYR B 101 PHE B 103 0 SHEET 2 AA6 3 CYS B 156 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 AA6 3 HIS B 172 THR B 175 -1 O THR B 175 N MET B 162 SHEET 1 AA7 7 VAL C 73 LEU C 75 0 SHEET 2 AA7 7 LEU C 67 ALA C 70 -1 N ALA C 70 O VAL C 73 SHEET 3 AA7 7 MET C 17 CYS C 22 -1 N GLN C 19 O GLN C 69 SHEET 4 AA7 7 THR C 25 LEU C 32 -1 O LEU C 27 N VAL C 20 SHEET 5 AA7 7 VAL C 35 PRO C 39 -1 O TYR C 37 N LEU C 30 SHEET 6 AA7 7 VAL C 86 VAL C 91 -1 O LEU C 87 N CYS C 38 SHEET 7 AA7 7 VAL C 77 GLN C 83 -1 N SER C 81 O LYS C 88 SHEET 1 AA8 5 LYS C 100 PHE C 103 0 SHEET 2 AA8 5 CYS C 156 GLU C 166 1 O VAL C 157 N LYS C 100 SHEET 3 AA8 5 VAL C 148 ASP C 153 -1 N ASN C 151 O SER C 158 SHEET 4 AA8 5 THR C 111 TYR C 118 -1 N SER C 113 O PHE C 150 SHEET 5 AA8 5 SER C 121 ALA C 129 -1 O SER C 123 N ALA C 116 SHEET 1 AA9 3 LYS C 100 PHE C 103 0 SHEET 2 AA9 3 CYS C 156 GLU C 166 1 O VAL C 157 N LYS C 100 SHEET 3 AA9 3 HIS C 172 THR C 175 -1 O ALA C 173 N MET C 165 LINK SG CYS A 145 C21 K36 A 401 1555 1555 1.64 LINK SG CYS B 145 C21 K36 B 401 1555 1555 1.64 LINK SG CYS C 145 C21 B1S C 401 1555 1555 1.67 LINK O ASN B 221 MG MG B 403 1555 1555 2.82 LINK OD1 ASN B 221 MG MG B 403 1555 1555 2.35 LINK O PHE B 223 MG MG B 403 1555 1555 2.02 LINK O ASP B 263 MG MG B 403 1555 1555 2.66 LINK OD1 ASP B 263 MG MG B 403 1555 1555 2.31 LINK MG MG B 403 O HOH B 524 1555 1555 2.37 SITE 1 AC1 15 HIS A 41 PHE A 140 ASN A 142 GLY A 143 SITE 2 AC1 15 SER A 144 CYS A 145 HIS A 163 HIS A 164 SITE 3 AC1 15 MET A 165 GLU A 166 GLN A 189 THR A 190 SITE 4 AC1 15 GLN A 192 HOH A 513 HOH A 599 SITE 1 AC2 5 LEU A 227 THR A 243 GLN A 244 ASP A 245 SITE 2 AC2 5 HOH A 519 SITE 1 AC3 6 PHE A 223 GLU A 270 GLN A 273 HOH A 509 SITE 2 AC3 6 HOH A 609 PRO C 168 SITE 1 AC4 2 TYR A 126 GLN A 127 SITE 1 AC5 1 PHE A 103 SITE 1 AC6 3 LEU A 58 MET A 82 ARG B 105 SITE 1 AC7 1 LEU B 67 SITE 1 AC8 5 ASN B 221 PHE B 223 ASP B 263 ALA B 266 SITE 2 AC8 5 HOH B 524 SITE 1 AC9 16 LEU B 27 ASN B 28 HIS B 41 PHE B 140 SITE 2 AC9 16 ASN B 142 GLY B 143 SER B 144 GLY B 146 SITE 3 AC9 16 SER B 147 HIS B 163 HIS B 164 MET B 165 SITE 4 AC9 16 GLU B 166 GLN B 189 THR B 190 GLN B 192 SITE 1 AD1 20 THR A 224 LEU C 27 ASN C 28 HIS C 41 SITE 2 AD1 20 MET C 49 PHE C 140 ASN C 142 GLY C 143 SITE 3 AD1 20 SER C 144 GLY C 146 SER C 147 HIS C 163 SITE 4 AD1 20 HIS C 164 MET C 165 GLU C 166 HIS C 172 SITE 5 AD1 20 ARG C 188 GLN C 189 THR C 190 GLN C 192 CRYST1 101.824 101.824 160.012 90.00 90.00 120.00 P 32 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009821 0.005670 0.000000 0.00000 SCALE2 0.000000 0.011340 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006250 0.00000